Cancer Foundation

Logo PR Newswire
HealthPress Release2023-03-28 17:15:00
The new effort will rapidly accelerate the pace of cancer innovation, building on the White House Cancer Moonshot BOSTON, March 28, 2023 /PRNewswire/ --...

Logo EIN Presswire
HealthPress Release2023-03-28 12:00:00
The Roster is a listing of nearly 250 public speakers, celebrities, and medical professionals available for National Cancer Survivors Day events. FRANKLIN,...

Logo GlobeNewswire
SciencePress Release2023-03-28 15:00:00
Martinsried /M unich, March 28, 202 3. Medigene AG (Medigene, FSE: MDG1, Prime Standard), an early-stage immuno-oncology platform company focusing on the...

Logo PR Newswire
SAN DIEGO and CALGARY, AB, March 28, 2023 /PRNewswire/ -- Oncolytics Biotech ® Inc. (NASDAQ: ONCY) (TSX: ONC) today announced that Dr. Matt Coffey, President...

Logo GlobeNewswire
SciencePress Release2023-03-28 20:01:00
SAN DIEGO and TORONTO, March 28, 2023 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (Nasdaq: APTO; TSX: APS), a clinical-stage precision oncology company...

Logo GlobeNewswire
SciencePress Release2023-03-28 12:30:00
WORCESTER, Mass., March 28, 2023 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (Mustang or the Company) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company...

Logo PR Newswire
HealthPress Release2023-03-28 10:00:00
American Lung Association volunteers ask members of Congress to take action to end lung cancer WASHINGTON, March 28, 2023 /PRNewswire/ -- Tomorrow, more than...

Logo PR Newswire
HealthPress Release2023-03-28 12:00:00
–The Sanderson Study is Freenome's study that pairs real-world data with multiomics for the detection of multiple cancers –Renown Health's William N....

Logo PR Newswire
HealthPress Release2023-03-28 11:00:00
CAMBRIDGE, Mass., March 28, 2023 /PRNewswire/ -- Theseus Pharmaceuticals, Inc. (NASDAQ: THRX) ("Theseus"), a clinical-stage biopharmaceutical company focused...

Logo Benzinga
Business / FinanceBy Globe Newswire2023-03-29 05:30:00
Continued progress in 2022 with corporate strategy update, end-to-end platform innovation, pipeline expansion, and acceleration of lead candidate development...

Logo PR Newswire
HealthPress Release2023-03-28 14:07:00
Brian Slomovitz, MD, Professor of Obstetrics/Gynecology and Division Director at Mount Sinai Medical Center presents trial results at The Society of...

Logo GlobeNewswire
SciencePress Release2023-03-29 05:30:00
Continued progress in 2022 with corporate strategy update, end-to-end platform innovation, pipeline expansion, and acceleration of lead candidate development...

Logo Benzinga
Business / FinanceBy Business Wire2023-03-28 17:07:00
Foothold Technology's AWARDS has achieved Office of the National Coordinator for Health Information Technology (ONC-Health IT) 2015 Edition Health IT...

Logo PR Newswire
HealthPress Release2023-03-29 07:08:00
STOCKHOLM, March 29, 2023 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), a leading developer of augmented intelligence-based solutions for skin...

Logo GlobeNewswire
SciencePress Release2023-03-28 12:30:00
SOLANA BEACH, Calif. and REDWOOD CITY, Calif., March 28, 2023 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the development of...

Logo Benzinga
Business / FinanceBy Business Wire2023-03-28 10:45:00
The long-term program is focused on significantly lowering the carbon footprint of Chemours' glycolic acid grades by up to 80% against a 2023 baseline The...

Logo PR Newswire
TechnologyPress Release2023-03-28 12:06:00
BOZEMAN, Mont., March 28, 2023 /PRNewswire/ -- The Dallas Foundation, the first community foundation in Texas, has implemented CommunitySuite, Grant...

Logo Benzinga
Business / FinanceBy Globe Newswire2023-03-28 20:02:00
Expanded clinical development footprint of BMF-219, the company's lead investigational, orally administered, covalent menin inhibitor, to eight liquid and...

Logo PR Newswire
LOS ANGELES, March 28, 2023 /PRNewswire/ -- SDS Capital Group's $150M Supportive Housing Fund (SHF or Fund), a first of its kind private equity fund to...

Logo Benzinga
HealthBy Vandana Singh2023-03-28 14:50:33
Merck & Co Inc MRK announced results from the Phase 3 NRGGY018 trial of Keytruda (pembrolizumab) combined with standard-of-care chemotherapy (carboplatin...